Analyze Diet
Journal of equine veterinary science2019; 88; 102874; doi: 10.1016/j.jevs.2019.102874

What Do We Know About Clodronate Now? A Medical and Veterinary Perspective.

Abstract: There has recently been some controversy over the use of bisphosphonates in horses and some confusion regarding the different classes of bisphosphonates and the differences between the mechanism of actions and effects of each class. This review article explores the different bisphosphonate classes and their different effects and mechanisms of action based on research from both the human and equine veterinary fields. This collaborative review between veterinary surgeons and medical doctors describes the latest use of bisphosphonates in humans and horses, including safety aspects, and allows comparisons to be drawn between the two fields. Potential future uses of bisphosphonates are also discussed.
Publication Date: 2019-11-23 PubMed ID: 32303308DOI: 10.1016/j.jevs.2019.102874Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Journal Article
  • Research Support
  • Non-U.S. Gov't
  • Review

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

This research article delves into the controversy surrounding the use of bisphosphonates in horses, examining different classes of the drug and their varying effects originating from studies in human and veterinary medicine. The collaborative review details the latest applications, safety measures, and potential future uses of bisphosphonates in both human and equine treatment.

Overview of Bisphosphonates

As per the article, bisphosphonates are a class of drugs typically used to treat osteoporosis and other bone diseases in humans. In veterinary medicine, particularly in equines, these drugs have also been used for treating bone-related disorders. However, the appropriateness and safety of using bisphosphonates in horses have recently come under controversy due to the potential side effects and unfamiliarity with the mechanism of action.

Different Classes of Bisphosphonates

  • The study describes how bisphosphonates can be categorized into different classes based on their chemical structure and mechanism of action. The classes include non-nitrogen-containing bisphosphonates and nitrogen-containing bisphosphonates.
  • Differences between these classes not only pertain to the structure but also to the distinct mechanisms of actions and effects they exert, which can lead to varied outcomes for human and animal patients.

Interdisciplinary Collaboration

  • A unique attribute of the paper is that it’s a collaborative effort between veterinary surgeons and medical doctors. This cross-sectional collaboration helps draw parallels between the use of bisphosphonates in human and veterinary medicine.
  • By pooling knowledge from both fields, the authors aim to provide a more comprehensive understanding of the implications of using bisphosphonates and consider future uses for the drug.

Safety Aspects and Future Potential of Bisphosphonates

  • The report discusses the safety aspects of bisphosphonates in both humans and horses. It brings forth the adverse effects, contraindications, and the importance of correct dosage, highlighting the need for careful analysis before treatment.
  • Alongside the current use, the authors also explore potential future uses of bisphosphonates, considering their efficacy and safety factors in treatments other than bone disorders.

Cite This Article

APA
Markell R, Saviola G, Barker EA, Conway JD, Dujardin C. (2019). What Do We Know About Clodronate Now? A Medical and Veterinary Perspective. J Equine Vet Sci, 88, 102874. https://doi.org/10.1016/j.jevs.2019.102874

Publication

ISSN: 0737-0806
NlmUniqueID: 8216840
Country: United States
Language: English
Volume: 88
Pages: 102874

Researcher Affiliations

Markell, Richard
  • Ranch & Coast Equine Practice, Inc, Bonsall, CA; IlluminX Consulting Inc, Bonsall, CA.
Saviola, Gianantonio
  • Istituti Clinici Scientifici Maugeri IRCCS, Rheumatology and Rehabilitation Unit of the Institute of Castel Goffredo, Mantua, Italy.
Barker, Elizabeth Ann
  • Dechra Veterinary Products EU, Shrewsbury, UK. Electronic address: lizzie.barker@dechra.com.
Conway, James Daniel
  • Dechra Veterinary Products US, Overland Park, KS.
Dujardin, Chris
  • Dechra Veterinary Products EU, 's-Hertogenbosch, Netherlands.

MeSH Terms

  • Animals
  • Clodronic Acid / therapeutic use
  • Diphosphonates / adverse effects
  • Horses

Citations

This article has been cited 3 times.
  1. Szalai Z, Bednárik J, Tóth BS, Takács A, Tekula S, Kőhidai L, Karaghiosoff K, Drahos L, Keglevich G. Cytotoxic Activity of Bisphosphonic Derivatives Obtained by the Michaelis-Arbuzov or the Pudovik Reaction. Pharmaceuticals (Basel) 2025 Jan 13;18(1).
    doi: 10.3390/ph18010091pubmed: 39861154google scholar: lookup
  2. Mass E. The stunning clodronate. J Exp Med 2023 Jun 5;220(6).
    doi: 10.1084/jem.20230339pubmed: 36976179google scholar: lookup
  3. Vergara-Hernandez FB, Nielsen BD, Colbath AC. Is the Use of Bisphosphonates Putting Horses at Risk? An Osteoclast Perspective. Animals (Basel) 2022 Jul 3;12(13).
    doi: 10.3390/ani12131722pubmed: 35804621google scholar: lookup